TABLE 2.
No. of participants |
No. of disease outcomes |
||||||
---|---|---|---|---|---|---|---|
Author, y (citation) | Total No. of participants | No. of treated/control | Any MI1 | CHD Death | Any CHD | Any stroke | All-cause mortality |
Comparisons of calcium supplements | |||||||
Baron et al., 1999 [21] | 930 | 464/466 | 35 | 16 | 46 | 20 | 47 |
Grant et al., 2005 [22] | 2643 | 1311/1332 | 84 | 99 | NA2 | 104 | 455 |
Prince et al., 2006 [23] | 1460 | 730/730 | 40 | 22 | 122 | 78 | 92 |
Reid et al., 2006 [24] | 1471 | 732/739 | 52 | NA | NA | 59 | 63 |
Bonnick et al., 2007 [25] | 563 | 282/281 | 0 | NA | NA | 3 | 3 |
Lappe et al., 2007 [26] | 733 | 445/288 | 4 | NA | NA | 9 | NA |
Baron et al., 2015 (17) | 834 | 419/415 | 4 | 5 | 9 | 2 | 13 |
ALL | 8634 | 4383/4251 | 219 | 142 | 177 | 275 | 673 |
Comparisons of calcium plus vitamin D supplements | |||||||
Chapuy et al., 1992 [5] | 3270 | 1634/1636 | NA | NA | NA | NA | 532 |
Chapuy et al., 2002 [27] | 583 | 389/194 | NA | NA | NA | NA | 116 |
Grant et al., 2005 [22] | 2638 | 1306/1332 | 83 | 83 | NA | 108 | 437 |
Jackson et al., 2006 [4] | 36,282 | 18,176/18,106 | 730 | 280 | 1010 | 726 | 1584 |
Salovaara et al., 2010 [28] | 3195 | 1586/1609 | 35 | 5 | 38 | 46 | 33 |
Baron et al., 2015 [27] | 836 | 421/415 | 6 | 7 | 13 | 5 | 15 |
ALL | 46,804 | 23,512/23,292 | 854 | 391 | 1061 | 885 | 2717 |
Any MI includes fatal MI and nonfatal MI.
N/A denotes not assessed.